Philippine-based healthcare technology company Philab Holdings Corp has approved plans to acquire a 67 per cent stake in local pharmaceutical firm Sydenham Laboratories Inc (SLI).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
